- Types of HIV drug
- Summary: Ways of attacking HIV
- Viruses
- HIVs life-cycle
- Multiple targets - combination therapy
- Reverse transcriptase inhibitors
- Protease inhibitors
- Preventing viral attachment or fusion
- Targeting other HIV proteins
- Inhibiting cellular factors required for HIV replication
- Other anti-HIV strategies
- Killing or removing HIV-infected cells
- Gene therapy
- Anti-oxidants
- Vitamins and minerals
- Treatment strategies
- Restoring the immune system
- Effectiveness of HIV therapy
Types of HIV drug
- Summary: Ways of attacking HIV
- Viruses
- HIVs life-cycle
- Multiple targets - combination therapy
- Reverse transcriptase inhibitors
- Protease inhibitors
- Preventing viral attachment or fusion
- Targeting other HIV proteins
- Inhibiting cellular factors required for HIV replication
- Other anti-HIV strategies
- Killing or removing HIV-infected cells
- Gene therapy
- Anti-oxidants
- Vitamins and minerals
latest aidsmap news
- Slow progress to expand rountine HIV testing in the US
- Concerns over miscarriage of justice after first UK conviction for transmission of hepatitis B
- High rate of death amongst patients with HIV diagnosed late
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Raltegravir may have role in PEP if exposure involves drug-resistant HIV
- Excellent outcomes from five years of antiretroviral use in Botswana
- Study explores verbal and non-verbal communication in unprotected sex between men
- IL-2 provides quick ‘AIDS rescue’, but effect does not always last
- Once-a-day etravirine should work as first-line treatment
- Second-line combinations fail twice as often as first-line ones in the first year
